Showing 281 - 300 results of 1,143 for search '"kidney disease"', query time: 0.08s Refine Results
  1. 281

    The Resistive Index Is a Marker of Renal Function, Pathology, Prognosis, and Responsiveness to Steroid Therapy in Chronic Kidney Disease Patients by Kikuno Hanamura, Akihiro Tojo, Satoshi Kinugasa, Kensuke Asaba, Toshiro Fujita

    Published 2012-01-01
    “…To evaluate the significance of the renal resistive index (RI) as a noninvasive marker of renal histological damage and a prognostic indicator, we examined RI by Doppler ultrasonography in 202 chronic kidney disease (CKD) patients who underwent renal biopsy. …”
    Get full text
    Article
  2. 282
  3. 283
  4. 284

    System Pharmacological Approach to Investigate and Validate Multitargeted and Therapeutic Effect of Furocoumarins of Apium graveolens L. for Treatment of Kidney Disease by null Yasheshwar, null Gaurav, Rustam Ekkbal, Prem Gupta, Rajendra Gyawali

    Published 2024-01-01
    “…The aim of the study was to apply a system pharmacological approach to investigate the multitarget therapeutic effects of furocoumarins of Apium graveolens L. for the treatment of kidney disease. Methods. Several furocoumarins of Apium graveolens were screened from online databases. …”
    Get full text
    Article
  5. 285
  6. 286

    Association of Calcium and Phosphate Levels with Incident Chronic Kidney Disease in Patients with Hypoparathyroidism: A Retrospective Case-Control Study by Elvira O. Gosmanova, Olulade Ayodele, Kristina Chen, Erin E. Cook, Fan Mu, Joshua A. Young, Lars Rejnmark

    Published 2022-01-01
    “…Reasons for the increased incidence of chronic kidney disease (CKD) in patients with chronic hypoparathyroidism are poorly understood. …”
    Get full text
    Article
  7. 287
  8. 288
  9. 289

    Gut microbiota and kidney function in autosomal dominant polycystic kidney disease participants in Cameroon: a cross-sectional study by Inès Obolo Nwaga, Victorine Bandolo Nzana, Rhoda Nsen Bughe, Isaac Dah, Cheboh Cho-Fon, Maimouna Mahamat, Emmanuelle Ndjong, Aristide Nono, Jean Claude Mballa, Fon Abongwa Acho, Vicky Ama Moor, Wilfred Fon Mbacham, François Folefack Kaze

    Published 2025-01-01
    “…Abstract Background and hypothesis Gut dysbiosis characterized by an imbalance in pathobionts (Enterobacter, Escherichia and Salmonella) and symbionts (Bifidobacterium, Lactobacillus and Prevotella) can occur during chronic kidney disease (CKD) progression. We evaluated the associations between representative symbionts (Bifidobacterium and Lactobacillus) and pathobionts (Enterobacteriaceae) with kidney function in persons with autosomal dominant polycystic kidney disease (ADPKD). …”
    Get full text
    Article
  10. 290

    Investigating the role of the metabolic score for visceral Fat in assessing the prevalence of chronic kidney disease from the NHANES 1999–2018 by Xingcheng Zhou, Jiayi Xiang, Shuxian Zhang, Jun Yang, Yi Tang, Yalan Wang

    Published 2025-01-01
    “…Abstract This study investigates the association between the Metabolic Score for Visceral Fat (METS-VF) and chronic kidney disease (CKD), assessing METS-VF as a potential predictor of CKD risk. …”
    Get full text
    Article
  11. 291

    Chronic kidney disease among people living with HIV on TDF based regimen: A systematic review and meta-analysis. by Taklo Simeneh Yazie, Wondimeneh Shibabaw Shiferaw, Asaye Alamneh Gebeyehu, Assefa Agegnehu Teshome, Zenaw Debasu Addisu, Abebe Muche Belete

    Published 2025-01-01
    “…<h4>Introduction</h4>Chronic kidney disease is a major public health concern among people living with human immunodeficiency virus (PLWHIV) who are taking tenofovir disoproxil fumarate-based regimen. …”
    Get full text
    Article
  12. 292
  13. 293
  14. 294

    The role of advanced practice nurses in improving healthcare outcomes for patients with chronic kidney disease: A scoping review protocol. by Hanako Nozu, Haruka Tamura, Takemi Kudo, Tomoko Araki, Hidetaka Sato, Takao Watanabe, Isoji Sasagawa

    Published 2024-01-01
    “…To clarify the overall aspect of advanced practice nurses' role, it is necessary to extract the studies illustrating advanced practice nurses' practices for patients with chronic kidney disease.<h4>Objective</h4>This study aims to map the literature describing the role of advanced practice nurses in improving healthcare outcomes for patients with chronic kidney disease.…”
    Get full text
    Article
  15. 295

    Early versus late nephrology referral and patient outcomes in chronic kidney disease: an updated systematic review and meta-analysis by Linan Cheng, Nan Hu, Di Song, Li Liu, Yuqing Chen

    Published 2025-01-01
    “…Early nephrology care should be promoted to improve the management of advanced chronic kidney disease.…”
    Get full text
    Article
  16. 296

    sST2 as a New Biomarker of Chronic Kidney Disease-Induced Cardiac Remodeling: Impact on Risk Prediction by Maëlle Plawecki, Marion Morena, Nils Kuster, Leila Chenine, Hélène Leray-Moragues, Bernard Jover, Pierre Fesler, Manuela Lotierzo, Anne-Marie Dupuy, Kada Klouche, Jean-Paul Cristol

    Published 2018-01-01
    “…Heart failure is the most frequent cardiac complication of chronic kidney disease (CKD). Biomarkers help identify high-risk patients. …”
    Get full text
    Article
  17. 297
  18. 298

    Meta-Analysis of Randomized Controlled Trials on Androgens versus Erythropoietin for Anaemia of Chronic Kidney Disease: Implications for Developing Countries by B. Adamu, S. M. Ma'aji, P. J. Erwin, I. M. Tleyjeh

    Published 2012-01-01
    “…To examine the efficacy and harms of androgens for the treatment of anaemia of chronic kidney disease (CKD) compared to EPO. Settings and Design. …”
    Get full text
    Article
  19. 299
  20. 300

    Leontiasis ossea in the setting of chronic kidney disease and limited dialysis access: A case report with discussion of therapeutic implications by Sebastian Maletz, BS, Zackery Beauchamp, MD, John Petrilli, MD, FAAFP

    Published 2025-03-01
    “…Leontiasis ossea, also known as craniofacial fibrous dysplasia, is a rare form of osseous hypertrophy of the facial bones associated with chronic kidney disease and secondary hyperparathyroidism. As the condition progresses, changes in bone structure can lead to severe facial disfigurement, respiratory difficulties, dysarthria, and dysphagia. …”
    Get full text
    Article